Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Cantor Fitzgerald 2021 Virtual Global Healthcare Conference September 27, 2021 1:20 PM ET Company Participants Doug Ingram - President and CEO Ian Estepan - EVP and CFO Conference Call Participants Alethia Young - Cantor Alethia Young Hey, everybody. It's Alethia Young here. I cover large-cap, small, mid-cap at Cantor, biotech, of course. Very happy to have Sarepta Therapeutics. I have Doug Ingram, who's the President and CEO; and Ian Estepan, who's the EVP and CFO. ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Morgan Stanley 19th Annual Global Healthcare Conference Call September 13, 2021 1:15 PM ET Company Participants Doug Ingram - Chief Executive Officer Ian Estepan - Chief Financial Officer Conference Call Participants Matthew Harrison - Morgan Stanley Matthew Harrison Well, good afternoon everybody. Thanks for joining us for our next session. I am Matthew Harrison, one of the biopharma analysts here at Morgan Stanley. Very pleased to have Sarepta with us for the next ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q2 2018 Results Conference Call August 4, 2021 4:30 PM ET Company Participants Mary Jenkins - Senior Manager, IR Doug Ingram - President and CEO Ian Estepan - EVP and CFO Dallan Murray - SVP and Chief Commercial Officer Dr. Gilmore O’Neill - EVP, R&D and Chief Medical Officer Dr. Louise Rodino-Klapac - EVP and Chief Scientific Officer Conference Call Participants Gena Wang - Barclays Tazeen Ahmad - BoA Brian Abrahams - RBC Capital Markets Alethia Young - Cantor Anupa ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14895 SAREPTA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 93-0797222 (State or other jurisdiction of incorporation or organization) 215 First Street, Suite 415 Cambridge, MA 02142 (Address of principal executive offices) (Zip Cod ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Bank of America Securities 2021 Napa BioPharma Virtual Conference June 16, 2021 10:30 AM ET Company Participants Doug Ingram - President and CEO Ian Estepan Stan - CFO Conference Call Participants Tazeen Ahmad - Bank of America Merrill Lynch Tazeen Ahmad Okay. Good morning, everybody. Thanks for joining us at the Bank of America Virtual Napa Conference. It's my pleasure this morning to have with us Sarepta as our next presenting company. For the next 50 minutes, I ha ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Goldman Sachs 42nd Annual Global Healthcare Conference Call June 10, 2021 1:20 PM ET Company Participants Douglas Ingram - President and Chief Executive Officer Ian Estepan - Executive Vice President and Chief Financial Officer Conference Call Participants Salveen Richter - Goldman Sachs Group, Inc. Salveen Richter Good afternoon, everyone. I'm Salveen Richter, biotechnology analyst at Goldman Sachs. Thanks for joining us. We are really pleased to have Sarepta with u ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) RBC Capital Markets Global Healthcare Conference May 18, 2021 2:30 PM ET Company Participants Ian Estepan - EVP & CFO Douglas Ingram - President, CEO & Director Conference Call Participants Brian Abrahams - RBC Capital Markets Q - Brian Abrahams Hi, good afternoon everyone. I'm Brian Abrahams, Senior Biotech Analyst at RBC Capital Markets. I'm really pleased to have with us our next presenting company, Sarepta Therapeutics, represented by their CFO, Ian Estepan. Ian, ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2021 Earnings Conference Call May 5, 2021 5:30 PM ET Company Participants Mary Jenkins - IR Douglas Ingram - President, CEO & Director Ian Estepan - EVP & CFO Dallan Murray - SVP & Chief Commercial Officer Gilmore O'Neill - EVP, R&D and Chief Medical Officer Louise Rodino-Klapac - EVP & Chief Scientific Officer Conference Call Participants Tazeen Ahmad - Bank of America Merrill Lynch Gil Blum - Needham & Company Colin Bristow - UBS Daniil Gataulin - Raymond James ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14895 SAREPTA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 93-0797222 (State or other juri ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Cowen 41st Annual Health Care Conference March 3, 2021 2:40 PM ET Company Participants Doug Ingram - Chief Executive Officer Conference Call Participants Ritu Baral - Cowen and Company Ritu Baral Hey, everyone. Thanks for joining us at the Sarepta fireside chat at the Cowen 2021 Health Care Conference. Hopefully, our first and only virtual health care conference for Cowen. With us from Sarepta, we have CEO, Doug Ingram; CFO, Ian Estepan; and CMO, Gilmore O'Neill, who ...